cryoICE cryoSPHERE+ Cryoablation Probe (CRYOSP) and 3 more
Device, Surgical, Cryogenic. 510(k) K233170, from AtriCure, Inc. (Mason, OH). Product code GXH, class 2.
As of Nov 19, 2026, K233170 is an FDA 510(k) held by AtriCure, Inc., substantially equivalent on Oct 26, 2023 after 29 days, with no recalls tied to it in FDA's recall database.
- Review time: 29 days
- Recalls: 0
FOR ADULT PATIENTS AtriCure’s cryoICE cryoSPHERE+ and cryoSPHERE MAX cryoablation probes are intended for use to temporarily block pain by ablating peripheral nerves performed by freezing target tissues, creating an inflammatory response (cryonecrosis).
- AtriCure cryoICE cryo-ablation probe (Cryo2), AAtriCure cryoICE cryoSPHERE cryoablation probe (CryoS, CryoS-L)K200697 · AtriCure, Inc. · Dec 23, 2020
- cryoICE cryoXT cryoablation probe (cryoXT)K250371 · AtriCure, Inc. · Apr 10, 2025
- iovera° SystemK243677 · Pacira Biosciences, Inc. · Dec 26, 2024
- AtriCure cryoICE BOX (ACM)K243157 · AtriCure, Inc. · Oct 29, 2024
- iovera SystemK220656 · Pacira Biosciences, Inc. · May 20, 2022
- Iovera SystemK211334 · Pacira Pharmaceuticals, Inc. · Sep 10, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Sep 27, 2023
- Review panel
- Neurology
- Regulation
- 21 CFR 882.4250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files